Pancreatic Cancer Research

ResearcherUniversidade Federal da BahiaNo recent work listed

Eleonora Lai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0275-8187; OpenAlex author ID A5076563915. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: 1 paper

Papers 6

  1. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine pl… Co-author DOI 10.1016/j.dld.2022.11.012↗
  2. How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world. Last author DOI 10.5306/wjco.v13.i5.417↗
  3. BRCA-mutant pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-021-01469-9↗
  4. Uncovering key targets of success for immunotherapy in pancreatic cancer. First author DOI 10.1080/14728222.2021.2010044↗
  5. Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus. Co-author DOI 10.1177/0300891620976945↗
  6. New therapeutic targets in pancreatic cancer. Co-author DOI 10.1016/j.ctrv.2019.101926↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mario Scartozzi · 6 shared papers, 2019–2023 · strength 0.68
  2. Andrea Pretta · 6 shared papers, 2019–2023 · strength 0.68
  3. Rossana Berardi · 1 shared paper, 2023 · strength 0.15
  4. Kalliopi Andrikou · 1 shared paper, 2021 · strength 0.09
  5. Giulia Rovesti · 1 shared paper, 2021 · strength 0.09
  6. Giulia Orsi · 1 shared paper, 2021 · strength 0.09
  7. Luca Faloppi · 1 shared paper, 2021 · strength 0.09
  8. Stefano Cascinu · 1 shared paper, 2021 · strength 0.09
  9. Francesco Sclafani · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.